Multidisciplinary and integrated solutions to influence and guide a drug discovery program from inception to IND filing

With comprehensive and expansive capabilities in biology, GVK BIO offers high-quality, cost-effective solutions across the pharma and biotech value chain. Biological assessment of New Molecular Entities (NMEs) plays a crucial role in ascertaining structure activity relationships, potency, selectivity, druggability, in vitro and in vivo efficacy evaluations.

• 100+ scientists in protein production, cell-line engineering, assay development and screening, in vitro toxicology, in vitro ADME, pharmacokinetics, in vivo efficacy and safety pharmacology.
• Access to multiple partnering options across the drug discovery chain, ensuring seamless, efficient and rapid implementation of research projects
• 100+ clients in the pharmaceutical, agrochemical and cosmeceutical sectors
• Our infrastructure includes an AAALAC approved vivarium and world class laboratories, instrumentation, and automation
• Highly experienced and globally trained scientific leadership

Custom solutions for drug discovery

From hit identification to clinical candidate selection:

• Reagent generation
• High-throughput screening
• Assay development
• Biomarker validation
• Radiometric assays
• DMPK
• Animal pharmacology (disease models)
• Exploratory toxicology